Cook Medical wins FDA nod for Zenith aortic dissection repair stent

This article was originally published here

Cook Medical Logo

Cook Medical said today that it won FDA approval for its Zenith Dissection endovascular system intended to treat Type B aortic dissections.

The Bloomington, Ind.-based company’s newly cleared system consists of a proximal stent-graft component and bare stent distal component and is intended to prove a less invasive alternative to open surgery for repairing Type B dissections of the descending thoracic aorta.

“We’re pleased to provide another minimally invasive option for aortic repair. The approval of this product gives us an opportunity to have a positive impact on the lives of patients with aortic dissections. Cook Medical is committed to developing a variety of treatment options for aortic disease –from the arch to the iliacs, in order to help physicians fit a device to each patient’s unique disease state,” Cook Medical vascular division VP Mark Breedlove said in a press release.

Cook Medical said that it plans to launch the device in the U.S. in the coming months.

Last month, Cook Medical said that it inked a deal to buy a former cigarette manufacturing plant in North Carolina.

The post Cook Medical wins FDA nod for Zenith aortic dissection repair stent appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply